Who reads Labiotech.eu?

Which Sectors?

Our audience hails from many fields

sectors-biotech-pharma-academia-communication-investor

Which Regions?

Our readers represent more than 45 countries

Which Companies?

Our Top Readers ❤️

Here is why they love us

“Building a real cool Biopharma community in Europe. That’s the real thing.”

Ingmar Hoerr, Co-founder & Chairman of CureVac

“Labiotech is putting EU biotech – one of the most dynamic European industries – centre-stage. It’s so worthwhile having you around and prosper!”

Regina Hodits, MP at Wellington Partners

“Labiotech really helps European biotech shine – both companies and the people behind them.”

Xavier Duportet, Co-founder & CEO at Eligo

“Young, fresh and with a great passion for our industry. And always fun to work with.”

Simon Moroney, CEO at Morphosys

“Labiotech is a valuable source to monitor and highlight the transformative breakthroughs happening in biotech. It’s therefore a useful reference point for Europa-Bio.”

Joanna Dupont, Secretary General at Europabio

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.